What is NDC 62135-313?

62135-313 is the product NDC for Anagrelide, Anagrelide hydrochloride anhydrous 1 mg/1 capsule, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Anagrelide hydrochloride anhydrous.

Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Anagrelide?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Anagrelide NDC 62135-313 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-313Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0313Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-313-60	62135031360	60 CAPSULE in 1 BOTTLE (62135-313-60)Marketed from Feb 5, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anagrelide
Generic name (nonproprietary): anagrelide
Active ingredients: Anagrelide hydrochloride anhydrous — 1 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Chartwell RX, LLCNDC labeler code 62135
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076683
Marketing start: Apr 18, 2005
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Platelet Production (Physiologic effect)Phosphodiesterase 3 Inhibitors (Mechanism)
Identifiers: Product ID 62135-313_13156e50-28d1-0994-e063-6394a90a16ecSPL ID 13156e50-28d1-0994-e063-6394a90a16ecSPL set ID e031dfb3-56e1-4fea-95f2-c2936e2057a0RxCUI 597850, 597852UNII VNS4435G39UPC 0362135312121, 0362135313609
Pharmacologic class: Platelet-reducing Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135031360 followed by a unit qualifier and the quantity

Package 62135-0313-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 7, 2024.

Indications (excerpt from the label)

Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. Anagrelide is a platelet reducing agent indicated for the treatment of thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62135-313

What is NDC 62135-313?: 62135-313 is the product NDC for Anagrelide, Anagrelide hydrochloride anhydrous 1 mg/1 capsule, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Anagrelide.
What is the active ingredient?: Anagrelide hydrochloride anhydrous.
Who is the labeler?: Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Anagrelide?: 5 other product NDCs are listed under this name. See all Anagrelide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Anagrelide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Anagrelide	Anagrelide hydrochloride .5 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-879	70954-0879-10
Anagrelide	Anagrelide hydrochloride 1 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-881	70954-0881-10
anagrelide	Anagrelide hydrochloride anhydrous .5 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-453	13668-0453-0113668-0453-30
anagrelide	Anagrelide hydrochloride anhydrous 1 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-462	13668-0462-0113668-0462-30
Anagrelide	Anagrelide hydrochloride anhydrous .5 mg/1	CapsuleOral	Chartwell RX, LLC	62135-312	62135-0312-12

Other NDCs under ANDA 076683

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076683
Product	Strength	Form · route	Labeler	Product NDC
Anagrelide	Anagrelide hydrochloride anhydrous .5 mg/1	CapsuleOral	Chartwell RX, LLC	62135-312